A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma (Q47108464)
Jump to navigation
Jump to search
scientific article published on 12 June 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma |
scientific article published on 12 June 2014 |
Statements
1 reference
A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma (English)
1 reference
Jedd D Wolchok
1 reference
Richard D Carvajal
1 reference
Michael K Wong
1 reference
John A Thompson
1 reference
Michael S Gordon
1 reference
Karl D Lewis
1 reference
Anna C Pavlick
1 reference
Patrick B Rojas
1 reference
Jonathan D Schwartz
1 reference
Agop Y Bedikian
1 reference
12 June 2014
1 reference
50
1 reference
12
1 reference
2099-2107
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference